alexa Editor - Junming Yue | University of Tennessee Health Science Ce | 18735
ISSN: 2576-1447

Journal of Cancer Science and Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Junming Yue

Junming Yue
Dr. Junming Yue Ph.D.
Assistant Professor 
The University of Tennessee Health Science Center
University of Tennessee Health Science Center


Junming Yue obtained his PhD degree at the Changchun University of Agriculture and Animal Sciences in 1996 from P.R. China. He had his postdoctoral training in the Institute of Molecular Biology and Biochemistry, Free University of Berlin, Germany and the Department of Physiology, the University of Tennessee Health Science Center (UTHSC), Memphis, USA. He continued his academic research as a research assistant professor in the University of Pittsburgh and UTHSC. Currently he is an assistant professor in the Department of Pathology and Laboratory Medicine, School of Medicine, the UTHSC. His research focuses on the miRNAs and human cancer, particularly in ovarian cancer.

Research Interest

Dr. Yue investigates how miRNAs regulate tumor cell proliferation, migration, apoptosis and metastasis. His lab uses lentiviral, adenoviral and adeno-associated viral vectors to deliver miRNA genes in cultured cells in vitro and mouse models in vivo to study the miRNA-mediated gene regulatory network by identifying their target genes and downstream signaling pathways, thus to develop miRNA based drugs in the treatment of ovarian cancer.



Global Speakers in the subject

Global Experts in the subject


Applications of CRSIPR/Cas9 in Cancer Research

Junming Yue, Ziyun Du, Fu-Ming Zhou, Peixin Dong and Lawrence M Pfeffer
Review Article: J Can Sci Res 2016, 1:103
DOI: 10.4172/2576-1447.1000103
Leave Your Message 24x7